Sentante
[PRIVATE]Service & Cobot Robotics · HQ: Vilnius, Lithuania · 1 model registered · 2 deployments
As of Sep 2026, DEPLOY verifies Sentante: 1 model, 2 deployments across 2 regions, $6.5M raised. 1 source back the record.
Ownership
PRIVATE
Capital / Funding
$7M
Headquarters
Vilnius, Lithuania
IP / Patents
Undisclosed
Platform Models
1
Audited Incidents
0
Overview
Sentante is a Vilnius-based medical robotics company developing an endovascular robotic platform with haptic force feedback and real-time guidance for remote vascular interventions. The first endovascular robot to complete an entire procedure in a clinical trial (ESSENTIAL, NCT06537947). Backed by €6M seed funding from Practica Capital and EIC Fund.
Clean safety record across 2 verified deployments. Deployment footprint remains limited relative to category peers.
- SURGICAL
Key Facts
Safety & Regulatory Posture
No incidents on record for Sentante.
Leadership & Founders
Current Program Leadership & Executives
CEO
Partnerships & Commercial Deployments
Operator Customers & Fleet Integrators
Platform Models
Deployments
Sectors & Applications
FAQ
What is Sentante?
Sentante is a Vilnius-based medical robotics company developing an endovascular robotic platform with haptic force feedback and real-time guidance for remote vascular interventions. The first endovascular robot to complete an entire procedure in a clinical trial (ESSENTIAL, NCT06537947). Backed by €6M seed funding from Practica Capital and EIC Fund.
What does Sentante make?
Sentante has 1 robot model on the DEPLOY registry: Sentante Endovascular Robotic Platform (Sentante builds physical robots).
Is Sentante publicly traded?
No. Sentante is privately held and not publicly traded, per the DEPLOY registry.
Who competes with Sentante?
On the DEPLOY registry, peer companies to Sentante building in the same form factors include Brainlab, EndoQuest Robotics, Intuitive Surgical, LEM Surgical.
Who is the CEO of Sentante?
Edvardas Satkauskas is the ceo of Sentante, per the DEPLOY registry.
How can I invest in Sentante?
Sentante is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $7M in disclosed funding.
Where is Sentante headquartered?
Sentante is headquartered in Vilnius, Lithuania.
How much funding has Sentante raised?
Sentante has raised approximately $7M in disclosed funding on record in the DEPLOY registry.
Who owns Sentante?
Sentante is privately held and venture-backed ($7M raised); ownership sits with its founders and private investors.
Where does Sentante operate robots?
Sentante operates 2 verified deployments, including at United States (multiple hotel chains), Germany, Europe.
How many robots has Sentante deployed?
DEPLOY has 2 verified Sentante deployments on record at sites including United States (multiple hotel chains), Germany, Europe. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.
Is Sentante a top robotics company?
On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Sentante ranks in roughly the top 32% of companies tracked by the registry.
Is Sentante safe?
Sentante has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.